Cumberland Pharmaceuticals (CPIX) Total Current Liabilities (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Total Current Liabilities data on file, last reported at $34.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 35.14% year-over-year to $34.5 million; the trailing twelve-month figure through Mar 2026 stood at $34.5 million (up 35.14% YoY), and the FY2025 full-year result was $36.7 million, up 16.2% from the prior year.
• Total Current Liabilities fell to $34.5 million in Q1 2026, from $36.7 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $36.7 million in Q4 2025 to a low of $24.0 million in Q2 2025.
• A 5-year average of $27.6 million and a median of $26.4 million in 2024 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities soared 48.24% in 2022 and declined 21.8% in 2025, its largest moves.
• Tracing CPIX's Total Current Liabilities over 5 years: stood at $28.6 million in 2022, then retreated by 2.09% to $28.0 million in 2023, then climbed by 13.01% to $31.6 million in 2024, then gained by 16.2% to $36.7 million in 2025, then slipped by 6.14% to $34.5 million in 2026.
• Business Quant data shows CPIX's Total Current Liabilities at $34.5 million in Q1 2026, $36.7 million in Q4 2025, and $24.3 million in Q3 2025.